Radiotherapy and Oncology

Article	Citations
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document	337
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group	153
Overview of artificial intelligence-based applications in radiotherapy: Recommendations for implementation and quality assurance	146
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement	140
Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial	126
Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer	112
A physicochemical model of reaction kinetics supports peroxyl radical recombination as the main determinant of the FLASH effect	102
Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial	97
Development and validation of a CT-based radiomic nomogram for preoperative prediction of early recurrence in advanced gastric cancer	91
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma	90
Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: Meta-analyses and a systematic review	87
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions	86
Metrics to evaluate the performance of auto-segmentation for radiation treatment planning: A critical review	86
What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plans	83
Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?	83
Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy	82
Radiotherapy Treatment plannINg study Guidelines (RATING): A framework for setting up and reporting on scientific treatment planning studies	77
Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma	75
A deep learning-based auto-segmentation system for organs-at-risk on whole-body computed tomography images for radiation therapy	74
Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac	72
Quantitative imaging for radiotherapy purposes	71
Low dose radiation therapy as a potential life saving treatment for COVID-19-induced acute respiratory distress syndrome (ARDS)	71
Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial)	68
The tubarial salivary glands: A potential new organ at risk for radiotherapy	68
Radiotherapy workflow and protection procedures during the Coronavirus Disease 2019 (COVID-19) outbreak: Experience of the Hubei Cancer Hospital in Wuhan, China	64

First experience with model-based selection of head and neck cancer patients for proton therapy	63
A deep learning approach to generate synthetic CT in low field MR-guided adaptive radiotherapy for abdominal and pelvic cases	62
A deep learning risk prediction model for overall survival in patients with gastric cancer: A multicenter study	62
May oxygen depletion explain the FLASH effect? A chemical track structure analysis	61
Auto-segmentation of pancreatic tumor in multi-parametric MRI using deep convolutional neural networks	60
Toxicity in combination immune checkpoint inhibitor and radiation therapy: A systematic review and meta-analysis	60
Mechanisms of radiation-induced endothelium damage: Emerging models and technologies	59
Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy	59
Deep learning-based synthetic CT generation for paediatric brain MR-only photon and proton radiotherapy	59
International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic	58
Is low dose radiation therapy a potential treatment for COVID-19 pneumonia?	58
ADC measurements on the Unity MR-linac – A recommendation on behalf of the Elekta Unity MR-linac consortium	58
Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results	58
Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience	57
Clinical implementation of deep learning contour autosegmentation for prostate radiotherapy	55
First magnetic resonance imaging-guided cardiac radioablation of sustained ventricular tachycardia	55
Partial breast irradiation with the 1.5 T MR-Linac: First patient treatment and analysis of electron return and stream effects	54
The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy	53
Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: A new concept for individually optimised treatment	53
The impact of Coronavirus (COVID-19) on head and neck cancer patients’ care	52
Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines	52
Clinical evaluation of atlas- and deep learning-based automatic segmentation of multiple organs and clinical target volumes for breast cancer	52
In vivo validation and tissue sparing factor for acute damage of pencil beam scanning proton FLASH	51
ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer	51
Automatic reconstruction of the delivered dose of the day using MR-linac treatment log files and online MR imaging	51
Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part II: Offline and online plan adaption for interfractional changes	51
Development and validation of a deep learning algorithm for auto-delineation of clinical target volume and organs at risk in cervical cancer radiotherapy	50
Magnetic resonance-based synthetic computed tomography images generated using generative adversarial networks for nasopharyngeal carcinoma radiotherapy treatment planning	50
Effect of COVID-19 pandemic on practice in European radiation oncology centers	49
Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable	48
The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines	48
Deep learning-based auto-segmentation of organs at risk in high-dose rate brachytherapy of cervical cancer	48
Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey	48
Automatic delineation of the clinical target volume and organs at risk by deep learning for rectal cancer postoperative radiotherapy	47
Improvement of prediction and classification performance for gamma passing rate by using plan complexity and dosiomics features	46
Reduction of clinical safety margins in proton therapy enabled by the clinical implementation of dual-energy CT for direct stopping-power prediction	46
Evaluation of interplay and organ motion effects by means of 4D dose reconstruction and accumulation	45
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial	45
The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review	44
A systematic review on the usage of averaged LET in radiation biology for particle therapy	44
A biochemical definition of cure after brachytherapy for prostate cancer	44
ESTRO ACROP guideline for target volume delineation of skull base tumors	43
Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials	43
Dose prediction with deep learning for prostate cancer radiation therapy: Model adaptation to different treatment planning practices	43
Fibroblast Activation Protein (FAP) specific PET for advanced target volume delineation in glioblastoma	43
Clinical paradigms and challenges in surface guided radiation therapy: Where do we go from here?	42
Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy	41
Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment	41
Dose prediction using a deep neural network for accelerated planning of rectal cancer radiotherapy	40
Delineation of whole heart and substructures in thoracic radiation therapy: National guidelines and contouring atlas by the Danish Multidisciplinary Cancer Groups	40

Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19	40
Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer	40
IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer	39
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)	39
First demonstration of the FLASH effect with ultrahigh dose rate high-energy X-rays	39
Radiation-induced risk of ischemic heart disease following breast cancer radiotherapy in Denmark, 1977–2005	39
International consensus recommendations for target volume delineation specific to sacral metastases and spinal stereotactic body radiation therapy (SBRT)	39
Deformable image registration uncertainty for inter-fractional dose accumulation of lung cancer proton therapy	39
Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma	38
68Ga-FAPI-PET/CT improves diagnostic staging and radiotherapy planning of adenoid cystic carcinomas – Imaging analysis and histological validation	38
Does the uncertainty in relative biological effectiveness affect patient treatment in proton therapy?	38
Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial	37
Proton therapy for head and neck squamous cell carcinomas: A review of the physical and clinical challenges	37
ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology	36
Clinical outcomes, local–regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab	36
Acute radiation-induced skin toxicity in hypofractionated vs. conventional whole-breast irradiation: An objective, randomized multicenter assessment using spectrophotometry	36
MRI-based delta-radiomics predicts pathologic complete response in high-grade soft-tissue sarcoma patients treated with neoadjuvant therapy	36
Clinical evaluation of a full-image deep segmentation algorithm for the male pelvis on cone-beam CT and CT	36
Integrating tumor and nodal radiomics to predict lymph node metastasis in gastric cancer	36
Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: Initial experience and dosimetric benefits	36
FLASH with carbon ions: Tumor control, normal tissue sparing, and distal metastasis in a mouse osteosarcoma model	35
Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal	35
A systematic review and meta-analysis of the prognostic value of radiomics based models in non-small cell lung cancer treated with curative radiotherapy	35
Current delivery limitations of proton PBS for FLASH	35
Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapy	34
Deep learning-enabled MRI-only photon and proton therapy treatment planning for paediatric abdominal tumours	34
Radiomics analysis of 3D dose distributions to predict toxicity of radiotherapy for lung cancer	34
ESTRO ACROP guidelines for target volume definition in pancreatic cancer	34
Multicentre, deep learning, synthetic-CT generation for ano-rectal MR-only radiotherapy treatment planning	34
Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon th	34
68Ga-fibroblast activation protein inhibitor PET/CT on gross tumour volume delineation for radiotherapy planning of oesophageal cancer	34
Grand challenges for medical physics in radiation oncology	33
Estimating dose delivery accuracy in stereotactic body radiation therapy: A review of in-vivo measurement methods	33
Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part I: Intra-fraction breathing motion management	33
ESTRO-ACROP guideline on surface guided radiation therapy	33
Carbon ion radiotherapy for sacral chordoma: A retrospective nationwide multicentre study in Japan	32
The risk for developing a secondary cancer after breast radiation therapy: Comparison of photon and proton techniques	32
Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis	32
ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma	32
Single fraction radiosurgery, fractionated radiosurgery, and conventional radiotherapy for spinal oligometastasis (SAFFRON): A systematic review and meta-analysis	32
Recommendations from gynaecological (GYN) GEC-ESTRO working group – ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancer	32
Cognitive impairment following radiation to hippocampus and other brain structures in adults with primary brain tumours	32
Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systems	32
Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis of phase III randomized trials	31
The role of computational methods for automating and improving clinical target volume definition	31
MetNet: Computer-aided segmentation of brain metastases in post-contrast T1-weighted magnetic resonance imaging	31
Update of the EPTN atlas for CT- and MR-based contouring in Neuro-Oncology	31
Navigating the challenges of the COVID-19 outbreak: Perspectives from the radiation oncology service in Singapore	31
Automated delineation of the clinical target volume using anatomically constrained 3D expansion of the gross tumor volume	31
Carbon ion radiotherapy in pancreatic cancer: A review of clinical data	31
Reirradiation of salivary gland tumors with carbon ion radiotherapy at CNAO	31
Risk of coronary artery disease after adjuvant radiotherapy in 29,662 early breast cancer patients: A population-based Danish Breast Cancer Group study	31
ESTRO ACROP guidelines for external beam radiotherapy of patients with complicated bone metastases	31
Definitive radiotherapy or surgery for early oral squamous cell carcinoma in old and very old patients: A propensity-score-matched, nationwide, population-based cohort study	30
Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment	30
A deep learning MR-based radiomic nomogram may predict survival for nasopharyngeal carcinoma patients with stage T3N1M0	30
Anatomic changes in head and neck intensity-modulated proton therapy: Comparison between robust optimization and online adaptation	30
Deep learning prediction of proton and photon dose distributions for paediatric abdominal tumours	29
ESTRO ACROP guidelines for external beam radiotherapy of patients with uncomplicated bone metastases	29
Linear accelerator-based radiosurgery is associated with lower incidence of radionecrosis compared with gamma knife for treatment of multiple brain metastases	29
Intraoperative radiation therapy (IORT) for soft tissue sarcoma – ESTRO IORT Task Force/ACROP recommendations	29
A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome	29
SPECT/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: A potentially practice-changing approach	29
Prediction of pseudoprogression and long-term outcome of vestibular schwannoma after Gamma Knife radiosurgery based on preradiosurgical MR radiomics	29
Risk and impact of radiation related lymphopenia in lung cancer: A systematic review and meta-analysis	29
An especially high rate of radiation pneumonitis observed in patients treated with thoracic radiotherapy and simultaneous osimertinib	28
Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations	28
Toxicity and cosmetic outcome after hypofractionated whole breast irradiation and boost-IOERT in early stage breast cancer (HIOB): First results of a prospective multicenter trial (NCT01343459)	28
Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma	28
4D CT image artifacts affect local control in SBRT of lung and liver metastases	27
Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?	27
Low dose radiation therapy for COVID-19 pneumonia: A double-edged sword	27
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus	27
The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancer	27
Cancer patients in Covid-19 era: Swimming against the tide	27
Electron dose rate and oxygen depletion protect zebrafish embryos from radiation damage	26
Beam pulse structure and dose rate as determinants for the flash effect observed in zebrafish embryo	26
Cardiac sub-volume targeting demonstrates regional radiosensitivity in the mouse heart	26
A tumor-immune interaction model for hepatocellular carcinoma based on measured lymphocyte counts in patients undergoing radiotherapy	26
Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma – How safe are protons?	26

Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma	26
GEC-ESTRO ACROP prostate brachytherapy guidelines	26
Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis	26
Impact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer	25
Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)	25
Prognostic value of multiparametric MRI-based radiomics model: Potential role for chemotherapeutic benefits in locally advanced rectal cancer	25
Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer	25
Head and neck cancer patients under (chemo-)radiotherapy undergoing nutritional intervention: Results from the prospective randomized HEADNUT-trial	25
Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy	25
Validation of an MR-guided online adaptive radiotherapy (MRgoART) program: Deformation accuracy in a heterogeneous, deformable, anthropomorphic phantom	25
Ablative radiotherapy for liver tumors using stereotactic MRI-guidance: A prospective phase I trial	24
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study	24
Key challenges in normal tissue complication probability model development and validation: towards a comprehensive strategy	24
Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: a systematic review	24
Pre-clinical validation of a novel system for fully-automated treatment planning	24
Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) – An analysis of UK’s largest cohort of lung SABR patients	24
Hypofractionated radiation therapy for breast cancer: Preferences amongst radiation oncologists in Europe – Results from an international survey	24
Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis	23
Pre-treatment radiomic features predict individual lymph node failure for head and neck cancer patients	23
Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: A multi-center retrospective study	23
Margin reduction in radiotherapy for glioblastoma through 18F-fluoroethyltyrosine PET? – A recurrence pattern analysis	23
Postoperative radiotherapy with intensity-modulated radiation therapy versus 3-dimensional conformal radiotherapy in early breast cancer: A randomized clinical trial of KROG 15-03	23
First experience of autonomous, un-supervised treatment planning integrated in adaptive MR-guided radiotherapy and delivered to a patient with prostate cancer	23
Pencil beam scanning proton FLASH maintains tumor control while normal tissue damage is reduced in a mouse model	23
Dose–response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control	23
Deciphering the epigenetic network in cancer radioresistance	23
Dose escalation to hypoxic subvolumes in head and neck cancer: A randomized phase II study using dynamic [18F]FMISO PET/CT	23
Normal tissue complication probability of vertebral compression fracture after stereotactic body radiotherapy for de novo spine metastasis	23
Towards the clinical implementation of intensity-modulated proton therapy for thoracic indications with moderate motion: Robust optimised plan evaluation by means of patient and machine specific infor	23
A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives	23
Final results of a dose escalation protocol of stereotactic body radiotherapy for poor surgical candidates with localized renal cell carcinoma	22
Prognostic importance of radiologic extranodal extension in nasopharyngeal carcinoma treated in a Canadian cohort	22
Non-operative management for oral cavity carcinoma: Definitive radiation therapy as a potential alternative treatment approach	22
Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: A nationwide population-based analysis	22
Radiation-induced lymphopenia during chemoradiation therapy for non-small cell lung cancer is linked with age, lung V5, and XRCC1 rs25487 genotypes in lymphocytes	22
Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trial	21
Urethral and bladder dose–effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trial	21
Prognostic factors and patterns of recurrence after curative resection for patients with distal cholangiocarcinoma	21
Implementing an online radiotherapy quality assurance programme with supporting continuous medical education – report from the EMBRACE-II evaluation of cervix cancer IMRT contouring	21
Patient-reported outcomes, physician-reported toxicities, and treatment outcomes in a modern cohort of patients with sinonasal cancer treated using proton beam therapy	21
A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer	21
An analysis of a large multi-institutional database reveals important associations between treatment parameters and clinical outcomes for stereotactic body radiotherapy (SBRT) of oligometastatic color	21
Stereotactic radioablation of ventricular arrhythmias in patients with structural heart disease – A systematic review	21
From multisource data to clinical decision aids in radiation oncology: The need for a clinical data science community	21
Deep learning for elective neck delineation: More consistent and time efficient	21
Psychological stress enhances tumor growth and diminishes radiation response in preclinical model of lung cancer	21
Prognostic significance of quantitative metastatic lymph node burden on magnetic resonance imaging in nasopharyngeal carcinoma: A retrospective study of 1224 patients from two centers	21
Influence of tumor necrosis on treatment sensitivity and long-term survival in nasopharyngeal carcinoma	21
Saliva electrolyte analysis and xerostomia-related quality of life in nasopharyngeal carcinoma patients following intensity-modulated radiation therapy	21
Distance to isocenter is not associated with an increased risk for local failure in LINAC-based single-isocenter SRS or SRT for multiple brain metastases	21
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement	21
Professional quality of life and burnout amongst radiation oncologists: The impact of alexithymia and empathy	21
Generalizability assessment of head and neck cancer NTCP models based on the TRIPOD criteria	21
Tricks and tips for target volume definition and delineation in breast cancer: Lessons learned from ESTRO breast courses	21
An evaluation of hepatocellular carcinoma practice guidelines from a radiation oncology perspective	21
Taste dysfunction following radiotherapy to the head and neck: A systematic review	21
Pencil beam scanning proton therapy for the treatment of craniopharyngioma complicated with radiation-induced cerebral vasculopathies: A dosimetric and linear energy transfer (LET) evaluation	21
Risk of ischaemic cerebrovascular events in head and neck cancer patients is associated with carotid artery radiation dose	20
Significant correlation between gross tumor volume (GTV) D98% and local control in multifraction stereotactic radiotherapy (MF-SRT) for unresected brain metastases	20
The role of surface-guided radiation therapy for improving patient safety	20
Current practice in proton therapy delivery in adult cancer patients across Europe	20
The role of combined ion-beam radiotherapy (CIBRT) with protons and carbon ions in a multimodal treatment strategy of inoperable osteosarcoma	20
Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure	20
Early health economic analysis of 1.5 T MRI-guided radiotherapy for localized prostate cancer: Decision analytic modelling	20
Radical radiotherapy for metachronous oligometastasis after initial treatment of esophageal cancer	20
How do patient-reported outcomes compare with clinician assessments? A prospective study of radiation dermatitis in breast cancer	20
Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer	20
Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency	20
Proton vs photon: A model-based approach to patient selection for reduction of cardiac toxicity in locally advanced lung cancer	20
Precision toxicity correlates of tumor spatial proximity to organs at risk in cancer patients receiving intensity-modulated radiotherapy	20
CT-guided versus MR-guided radiotherapy: Impact on gastrointestinal sparing in adrenal stereotactic body radiotherapy	20
A deep learning approach to generate synthetic CT in low field MR-guided radiotherapy for lung cases	20
Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer – The RAPIDO trial	20
Identification of treatment error types for lung cancer patients using convolutional neural networks and EPID dosimetry	20
Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: A retrospective single center study	20
Watch-and-wait strategy in rectal cancer: Is there a tumour size limit? Results from two pooled prospective studies	20
Accelerating prostate stereotactic ablative body radiotherapy: Efficacy and toxicity of a randomized phase II study of 11 versus 29 days overall treatment time (PATRIOT)	19
Association of tumor genomic factors and efficacy for metastasis-directed stereotactic body radiotherapy for oligometastatic colorectal cancer	19
Predicting outcomes in anal cancer patients using multi-centre data and distributed learning – A proof-of-concept study	19
Advances in cancer imaging require renewed radiotherapy dose and target volume concepts	19
Radiotherapy as nose preservation treatment strategy for cancer of the nasal vestibule: The Dutch experience	19
Re-irradiation in the thorax – An analysis of efficacy and safety based on accumulated EQD2 doses	19
First experimental demonstration of VMAT combined with MLC tracking for single and multi fraction lung SBRT on an MR-linac	19
Stereotactic body radiation therapy for hepatocellular carcinoma with Macrovascular invasion	19
Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemotherapy for locally advanced pancreatic cancer	19
Combined proton–photon treatments – A new approach to proton therapy without a gantry	19
ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer	19
Accuracy and precision of apparent diffusion coefficient measurements on a 1.5 T MR-Linac in central nervous system tumour patients	19
Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiomic signatures	19
Development and validation of a radiomics signature on differentially expressed features of 18F-FDG PET to predict treatment response of concurrent chemoradiotherapy in thoracic esophagus squamous cel	19
Towards homogenization of total body irradiation practices in pediatric patients across SIOPE affiliated centers. A survey by the SIOPE radiation oncology working group	19
Metformin: (future) best friend of the radiation oncologist?	19
Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma	19
Intensified systemic therapy and stereotactic ablative radiotherapy dose for patients with unresectable pancreatic adenocarcinoma	19
Impact of sarcopenia on acute radiation-induced toxicity in head and neck cancer patients	19